{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:06:36Z","timestamp":1792789596809,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00467-021-05358-4","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T08:04:06Z","timestamp":1646294646000},"page":"1747-1757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Furosemide and albumin for the treatment of nephrotic edema: a systematic review"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4685-0612","authenticated-orcid":false,"given":"Erin","family":"Hedin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vid","family":"Bijeli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Barrowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"5358_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s004670000512","volume":"16","author":"JG Vande Walle","year":"2001","unstructured":"Vande Walle JG, Donckerwolcke RA (2001) Pathogenesis of edema formation in the nephrotic syndrome. Pediatr Nephrol 16:283\u2013293","journal-title":"Pediatr Nephrol"},{"key":"5358_CR2","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00467-013-2567-8","volume":"29","author":"MA Cadnapaphornchai","year":"2014","unstructured":"Cadnapaphornchai MA, Tkachenko O, Shchekochikhin D, Schrier RW (2014) The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediatr Nephrol 29:1159\u20131167. https:\/\/doi.org\/10.1007\/s00467-013-2567-8","journal-title":"Pediatr Nephrol"},{"key":"5358_CR3","first-page":"836","volume":"21","author":"M Zacchia","year":"2008","unstructured":"Zacchia M, Trepiccione F, Morelli F, Pani A, Capasso G (2008) Nephrotic syndrome: new concepts in the pathophysiology of sodium retention. J Nephrol 21:836\u2013842","journal-title":"J Nephrol"},{"key":"5358_CR4","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1681\/ASN.V102323","volume":"10","author":"JG Vande Walle","year":"1999","unstructured":"Vande Walle JG, Donckerwolcke RA, Koomans HA (1999) Pathophysiology of edema formation in children with nephrotic syndrome not due to minimal change disease. J Am Soc Nephrol 10:323\u2013331","journal-title":"J Am Soc Nephrol"},{"key":"5358_CR5","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1007\/s00467-007-0521-3","volume":"22","author":"A Doucet","year":"2007","unstructured":"Doucet A, Favre G, Desch\u00eanes G (2007) Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications. Pediatr Nephrol 22:1983\u20131990. https:\/\/doi.org\/10.1007\/s00467-007-0521-3","journal-title":"Pediatr Nephrol"},{"key":"5358_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1345\/aph.1C320","volume":"37","author":"RJ Elwell","year":"2003","unstructured":"Elwell RJ, Spencer AP, Eisele G (2003) Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother 37:695\u2013700. https:\/\/doi.org\/10.1345\/aph.1C320","journal-title":"Ann Pharmacother"},{"key":"5358_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1046\/j.1523-1755.1999.00298.x","volume":"55","author":"D Fliser","year":"1999","unstructured":"Fliser D, Zurbr\u00fcggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, Ritz E (1999) Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int 55:629\u2013634. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00298.x","journal-title":"Kidney Int"},{"key":"5358_CR8","first-page":"598","volume":"21","author":"G Gonz\u00e1lez-Mart\u00edn","year":"1983","unstructured":"Gonz\u00e1lez-Mart\u00edn G, Bravo I, Ibarra N, Arancibia A (1983) Clinical pharmacokinetics of furosemide in children with nephrotic syndrome. Int J Clin Pharmacol 21:598\u2013601","journal-title":"Int J Clin Pharmacol"},{"key":"5358_CR9","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1681\/ASN.V1161100","volume":"11","author":"R Agarwal","year":"2000","unstructured":"Agarwal R, Gorski JC, Sundblad K, Brater DC (2000) Urinary protein binding does not affect response to furosemide in patients with nephrotic syndrome. J Am Soc Nephrol 11:1100\u20131105. https:\/\/doi.org\/10.1681\/ASN.V1161100","journal-title":"J Am Soc Nephrol"},{"key":"5358_CR10","doi-asserted-by":"publisher","unstructured":"Ho JJ, Adnan AS, Kueh YC, Ambak NJ, Van Rostenberghe H, Jummaat F (2019) Human albumin infusion for treating oedema in people with nephrotic syndrome. Cochrane Database Syst Rev 7:CD009692. https:\/\/doi.org\/10.1002\/14651858.CD009692.pub2","DOI":"10.1002\/14651858.CD009692.pub2"},{"key":"5358_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jcrc.2013.10.004","volume":"29","author":"GD Kitsios","year":"2014","unstructured":"Kitsios GD, Mascari P, Ettunsi R, Gray AW (2014) Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. J Crit Care 29:253\u2013259. https:\/\/doi.org\/10.1016\/j.jcrc.2013.10.004","journal-title":"J Crit Care"},{"key":"5358_CR12","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ, Elbers RG, et al. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org\/handbook. In.","DOI":"10.1002\/9781119536604.ch8"},{"key":"5358_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"5358_CR14","doi-asserted-by":"publisher","unstructured":"Chandler J, McKenzie J, Boutron I, Welch V (eds) (2016) Cochrane methods. Cochrane Database Syst Rev (10 Suppl 1). https:\/\/doi.org\/10.1002\/14651858.CD201601","DOI":"10.1002\/14651858.CD201601"},{"key":"5358_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/31.1.140","volume":"31","author":"DR Elbourne","year":"2002","unstructured":"Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A (2002) Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 31:140\u2013149. https:\/\/doi.org\/10.1093\/ije\/31.1.140","journal-title":"Int J Epidemiol"},{"key":"5358_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3102\/10769986006002107","volume":"6","author":"LV Hedges","year":"1981","unstructured":"Hedges LV (1981) Distribution theory for glass\u2019s estimator of effect size and related estimators. J Educ Stat 6:107\u2013128. https:\/\/doi.org\/10.3102\/10769986006002107","journal-title":"J Educ Stat"},{"key":"5358_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22:153\u2013160. https:\/\/doi.org\/10.1136\/ebmental-2019-300117","journal-title":"Evid Based Ment Health"},{"key":"5358_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"5358_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3346\/jkms.2001.16.4.448","volume":"16","author":"KY Na","year":"2001","unstructured":"Na KY, Han JS, Kim YS, Ahn C, Kim S, Lee JS, Bae KS, Jang IJ, Shin SG, Huh W, Jeon US (2001) Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome? J Korean Med Sci 16:448\u2013454. https:\/\/doi.org\/10.3346\/jkms.2001.16.4.448","journal-title":"J Korean Med Sci"},{"key":"5358_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1136\/bmj.310.6973.162","volume":"310","author":"F Akcicek","year":"1995","unstructured":"Akcicek F, Yalniz T, Basci A, Ok E, Mees EJ (1995) Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin? BMJ 310:162\u2013163. https:\/\/doi.org\/10.1136\/bmj.310.6973.162","journal-title":"BMJ"},{"key":"5358_CR21","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00467-008-1062-0","volume":"24","author":"R Dharmaraj","year":"2009","unstructured":"Dharmaraj R, Hari P, Bagga A (2009) Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. Pediatr Nephrol 24:775\u2013782. https:\/\/doi.org\/10.1007\/s00467-008-1062-0","journal-title":"Pediatr Nephrol"},{"key":"5358_CR22","first-page":"471","volume":"22","author":"A Ghafari","year":"2011","unstructured":"Ghafari A, Mehdizadeh A, Alavi-Darazam I, Rahimi E, Kargar C, Sepehrvand N (2011) Co-administration of albumin-furosemide in patients with the nephrotic syndrome. Saudi J Kidney Dis Transpl 22:471\u2013475","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"5358_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2215\/CJN.04390808","volume":"4","author":"G Kapur","year":"2009","unstructured":"Kapur G, Valentini RP, Imam AA, Mattoo TK (2009) Treatment of severe edema in children with nephrotic syndrome with diuretics alone\u2013a prospective study. Clin J Am Soc Nephrol 4:907\u2013913. https:\/\/doi.org\/10.2215\/CJN.04390808","journal-title":"Clin J Am Soc Nephrol"},{"key":"5358_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/s0140-6736(95)91210-x","volume":"346","author":"JG Vande Walle","year":"1995","unstructured":"Vande Walle JG, Donckerwolcke RA, van Isselt JW, Derkx FH, Joles JA, Koomans HA (1995) Volume regulation in children with early relapse of minimal-change nephrosis with or without hypovolaemic symptoms. Lancet 346:148\u2013152. https:\/\/doi.org\/10.1016\/s0140-6736(95)91210-x","journal-title":"Lancet"},{"key":"5358_CR25","doi-asserted-by":"publisher","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC (2015) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev (3):CD001533. https:\/\/doi.org\/10.1002\/14651858.CD001533.pub5","DOI":"10.1002\/14651858.CD001533.pub5"},{"key":"5358_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","volume":"43","author":"A Pasini","year":"2017","unstructured":"Pasini A, Benetti E, Conti G, Ghio L et al (2017) The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: part I - diagnosis and treatment of the first episode and the first relapse. Ital J Pediatr 43:41. https:\/\/doi.org\/10.1186\/s13052-017-0356-x","journal-title":"Ital J Pediatr"},{"key":"5358_CR27","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1542\/peds.91.6.1142","volume":"91","author":"RM Haws","year":"1993","unstructured":"Haws RM, Baum M (1993) Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics 91:1142\u20131146","journal-title":"Pediatrics"},{"key":"5358_CR28","first-page":"102","volume":"4","author":"S Lee","year":"2000","unstructured":"Lee S, Jeong J, Hwang S (2000) The effect of human albumin infusion on the clinical course of steroid sensitive nephrotic syndrome. J Korean Soc Pediatr Nephrol 4:102\u2013110","journal-title":"J Korean Soc Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05358-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-05358-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-05358-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T07:19:45Z","timestamp":1657091985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-05358-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["5358"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-05358-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have consented to publication if accepted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}